Marimed (MRMD) Shares Outstanding (Diluted Average) (2018 - 2026)

Marimed (MRMD) has 9 years of Shares Outstanding (Diluted Average) data on file, last reported at $397.4 million in Q1 2026.

• Shares Outstanding (Diluted Average) for Q1 2026 came in at $397.4 million, up 3.89% year-over-year; the trailing twelve-month figure through Mar 2026 was $397.4 million (up 3.89% YoY), and the FY2025 annual result was $390.1 million, up 2.9% from the prior year.
• Shares Outstanding (Diluted Average) grew to $397.4 million in Q1 2026 per MRMD's latest filing, from $390.1 million in the prior quarter.
• Over five years, Shares Outstanding (Diluted Average) peaked at $397.4 million in Q1 2026 and troughed at $342.8 million in Q1 2023.
• A 5-year average of $377.8 million and a median of $379.2 million in 2024 frame the typical range for Shares Outstanding (Diluted Average).
• The sharpest annual moves came in 2022 and 2023: Shares Outstanding (Diluted Average) grew 11.17% in 2022, then declined 9.53% in 2023.
• A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $380.3 million in 2022, then fell by 4.44% to $363.4 million in 2023, then advanced by 4.33% to $379.2 million in 2024, then gained by 2.9% to $390.1 million in 2025, then advanced by 1.87% to $397.4 million in 2026.
• Business Quant data shows MRMD's Shares Outstanding (Diluted Average) at $397.4 million in Q1 2026, $390.1 million in Q4 2025, and $392.6 million in Q3 2025.